Squarepoint’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-92,983
| Closed | -$39.1K | – | 5640 |
|
|
2024
Q4 | $39.1K | Buy |
+92,983
| New | +$77.7K | ﹤0.01% | 4879 |
|
|
2023
Q4 | – | Sell |
-149
| Closed | -$3.3K | – | 4629 |
|
|
2023
Q3 | $3.3K | Buy |
+149
| New | +$3.89K | ﹤0.01% | 3721 |
|
|
2021
Q1 | – | Sell |
-31
| Closed | -$195K | – | 3743 |
|
|
2020
Q4 | $195K | Sell |
31
-69
| -69% | -$422K | ﹤0.01% | 2527 |
|
|
2020
Q3 | $679K | Buy |
100
+39
| +64% | +$289K | 0.01% | 1215 |
|
|
2020
Q2 | $389K | Buy |
+61
| New | +$259K | 0.01% | 1440 |
|
|
2019
Q1 | – | Sell |
-11
| Closed | -$162K | – | 2507 |
|
|
2018
Q4 | $162K | Buy |
11
+4
| +57% | +$94K | ﹤0.01% | 1743 |
|
|
2018
Q3 | $270K | Buy |
+7
| New | +$231K | ﹤0.01% | 1593 |
|
|
2017
Q4 | – | Sell |
-3
| Closed | -$59K | – | 2394 |
|
|
2017
Q3 | $59K | Buy |
+3
| New | +$55.7K | ﹤0.01% | 1553 |
|
Squarepoint's TTOO Position: Q1 2025 in Review
Squarepoint sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 92,983 shares — an estimated $39.1K sold.
Squarepoint first reported a position in TTOO in Q3 2017 and held it in 8 quarters. The position peaked at $679K in Q3 2020. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- Squarepoint reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- Squarepoint sold 92,983 T2 Biosystems, Inc shares in Q1 2025, an estimated $39.1K.
- Squarepoint first reported a position in T2 Biosystems, Inc in Q3 2017 and held it in 8 quarters.
- Squarepoint's T2 Biosystems, Inc position peaked at $679K in Q3 2020.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.